Sodium Alginate (Gaviscon®) does not reduce apnoeas related to gastro-oesophageal reflux in preterm infants

Early Hum Dev. 2011 Dec;87(12):775-8. doi: 10.1016/j.earlhumdev.2011.05.013. Epub 2011 Jun 22.

Abstract

Background: Apnoea of prematurity (AOP) frequently recurs in preterm infants. We have previously shown that a significant but variable proportion of AOP is induced by gastro-oesophageal reflux (GOR).

Aim: The aim of this study is to evaluate the efficacy of sodium alginate in reducing the frequency of GOR-related AOP.

Subjects: Twenty-eight preterm infants with AOP were studied by a six-hour recording of combined multichannel intraluminal impedance and pH monitoring and polysomnography, including two three-hour postprandial periods: sodium alginate was given after one single meal named as drug-given (DG) meal, while the other as drug-free (DF).

Results: During 165h of registration, 715 apnoeas were recorded, 368 after-DG and 347 after-DF (p=.99); furthermore, 851 GOR episodes were detected, 315 after-DG and 536 after-DF (p=.001). No differences in the number of AOP were found between DG and DF. A significant reduction in the number of acid GORs and in acid exposure was found during DG, while the administration of sodium alginate didn't influence non-acid GOR indexes. The frequency of GOR-related apnoeas didn't differ between DG and DF.

Discussion: Sodium alginate doesn't reduce the total number of AOP nor GOR-related apnoeas. On the other hand, it reduces acid GOR features, while it had no effect on non-acid GOR indexes.

Publication types

  • Clinical Trial

MeSH terms

  • Alginates / therapeutic use*
  • Aluminum Hydroxide / therapeutic use*
  • Apnea / complications
  • Apnea / drug therapy*
  • Drug Combinations
  • Female
  • Gastroesophageal Reflux / complications
  • Gastroesophageal Reflux / drug therapy*
  • Glucuronic Acid / therapeutic use
  • Hexuronic Acids / therapeutic use
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases / drug therapy*
  • Male
  • Silicic Acid / therapeutic use*
  • Sodium Bicarbonate / therapeutic use*

Substances

  • Alginates
  • Drug Combinations
  • Hexuronic Acids
  • Silicic Acid
  • Aluminum Hydroxide
  • alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination
  • Glucuronic Acid
  • Sodium Bicarbonate